Mirion Technologies Inc
MIR23.535USD
+0.315+1.36%
Close 12/19, 16:00（ET）Quotes delayed by 15 min
5.67BMarket Cap
185.53P/E TTM
More Details of Mirion Technologies Inc Company
Mirion Technologies, Inc. is a global provider of radiation detection, measurement, analysis, and monitoring solutions to the medical, nuclear, defense, and research end markets. The Company's segments include Nuclear & Safety and Medical. The Medical includes products and services for radiation therapy, nuclear medicine and personal dosimetry. This segment’s principal product offering is Radiation Therapy Quality Assurance, which includes solutions for calibrating and/or verifying imaging, treatment machine, patient treatment plan, and patient treatment accuracy. The Nuclear & Safety includes products and services focused on addressing critical radiation safety, measurement and analysis applications across nuclear energy, laboratories and research and other industrial markets such as defense. For Nuclear Power Plants (NPPs), it sells products and services for use at any stage of their life (construction, operation, decommissioning and dismantling).
Mirion Technologies Inc Info
Ticker SymbolMIR
Company nameMirion Technologies Inc
IPO dateJun 29, 2020
CEOLogan (Thomas D)
Number of employees2860
Security typeOrdinary Share
Fiscal year-endJun 29
Address1218 Menlo Drive
CityATLANTA
Stock exchangeNASDAQ OMX NASDAQ Basic NYSE
CountryUnited States of America
Postal code30318
Phone17704322744
Websitehttps://www.mirion.com/
Ticker SymbolMIR
IPO dateJun 29, 2020
CEOLogan (Thomas D)
Company Executives of Mirion Technologies Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Lawrence D. (Larry) Kingsley
Mr. Lawrence D. (Larry) Kingsley
Independent Director
Independent Director
4.76M
+0.02%
Mr. Brian Schopfer
Mr. Brian Schopfer
Chief Financial Officer
Chief Financial Officer
751.13K
-0.33%
Mr. Loic Eloy
Mr. Loic Eloy
Group President - Nuclear and Safety
Group President - Nuclear and Safety
78.83K
-36.34%
Mr. Kenneth C. Bockhorst
Mr. Kenneth C. Bockhorst
Lead Independent Director
Lead Independent Director
76.18K
+11.70%
Mr. John W. Kuo, J.D.
Mr. John W. Kuo, J.D.
Independent Director
Independent Director
74.22K
+1.40%
Mr. Robert A. (Rob) Cascella
Mr. Robert A. (Rob) Cascella
Independent Director
Independent Director
50.04K
+18.96%
Ms. Emmanuelle Lee
Ms. Emmanuelle Lee
Chief Legal Officer, Chief Compliance Office, Deputy General Counsel
Chief Legal Officer, Chief Compliance Office, Deputy General Counsel
42.93K
-22.55%
Mrs. Alison Ulrich
Mrs. Alison Ulrich
Chief Human Resources Officer
Chief Human Resources Officer
16.28K
-14.94%
Ms. Jody A. Markopoulos
Ms. Jody A. Markopoulos
Independent Director
Independent Director
--
--
Mr. Eric Linn
Mr. Eric Linn
Investor Relations
Investor Relations
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Lawrence D. (Larry) Kingsley
Mr. Lawrence D. (Larry) Kingsley
Independent Director
Independent Director
4.76M
+0.02%
Mr. Brian Schopfer
Mr. Brian Schopfer
Chief Financial Officer
Chief Financial Officer
751.13K
-0.33%
Mr. Loic Eloy
Mr. Loic Eloy
Group President - Nuclear and Safety
Group President - Nuclear and Safety
78.83K
-36.34%
Mr. Kenneth C. Bockhorst
Mr. Kenneth C. Bockhorst
Lead Independent Director
Lead Independent Director
76.18K
+11.70%
Mr. John W. Kuo, J.D.
Mr. John W. Kuo, J.D.
Independent Director
Independent Director
74.22K
+1.40%
Mr. Robert A. (Rob) Cascella
Mr. Robert A. (Rob) Cascella
Independent Director
Independent Director
50.04K
+18.96%
Revenue Breakdown
Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
By BusinessUSD
Name
Revenue
Proportion
Nuclear
82.10M
36.83%
Cancer care
62.20M
27.90%
Nuclear and safety-Other
32.20M
14.45%
Labs and research
27.40M
12.29%
Medical-Other
19.00M
8.52%
By RegionUSD
Name
Revenue
Proportion
Northern America
138.90M
62.31%
Europe
81.80M
36.70%
Asia Pacific
2.20M
0.99%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Nuclear
82.10M
36.83%
Cancer care
62.20M
27.90%
Nuclear and safety-Other
32.20M
14.45%
Labs and research
27.40M
12.29%
Medical-Other
19.00M
8.52%
Shareholding Stats
Updated: Tue, Nov 18
Updated: Tue, Nov 18
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
13.13%
The Vanguard Group, Inc.
12.25%
T. Rowe Price Investment Management, Inc.
8.70%
State Street Investment Management (US)
3.56%
Omega Advisors, Inc.
3.38%
Other
58.98%
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
13.13%
The Vanguard Group, Inc.
12.25%
T. Rowe Price Investment Management, Inc.
8.70%
State Street Investment Management (US)
3.56%
Omega Advisors, Inc.
3.38%
Other
58.98%
Shareholder Types
Shareholders
Proportion
Investment Advisor
58.18%
Investment Advisor/Hedge Fund
32.30%
Hedge Fund
7.72%
Individual Investor
3.75%
Family Office
3.46%
Research Firm
2.16%
Pension Fund
0.94%
Bank and Trust
0.80%
Sovereign Wealth Fund
0.07%
Institutional Shareholding
Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
568
218.98M
88.36%
+5.81M
2025Q2
482
202.24M
88.76%
-16.70M
2025Q1
461
196.77M
87.24%
-13.76M
2024Q4
413
201.38M
89.23%
-34.17M
2024Q3
364
208.86M
92.88%
-24.70M
2024Q2
347
200.91M
91.31%
-22.95M
2024Q1
340
192.50M
88.03%
-24.17M
2023Q4
330
191.09M
87.68%
-28.19M
2023Q3
353
191.03M
87.66%
-36.72M
2023Q2
372
194.38M
89.64%
-28.89M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
BlackRock Institutional Trust Company, N.A.
14.04M
5.75%
-349.46K
-2.43%
Jun 30, 2025
The Vanguard Group, Inc.
23.72M
9.71%
+505.18K
+2.18%
Jun 30, 2025
T. Rowe Price Investment Management, Inc.
20.96M
8.58%
+247.13K
+1.19%
Jun 30, 2025
State Street Investment Management (US)
5.09M
2.09%
-45.50K
-0.89%
Jun 30, 2025
Omega Advisors, Inc.
7.13M
2.92%
+100.00K
+1.42%
Jun 30, 2025
Janus Henderson Investors
7.99M
3.27%
-599.27K
-6.98%
Jun 30, 2025
Dimensional Fund Advisors, L.P.
6.95M
2.84%
-416.57K
-5.66%
Jun 30, 2025
Geode Capital Management, L.L.C.
4.74M
1.94%
+471.00
+0.01%
Jun 30, 2025
MFS Investment Management
3.83M
1.57%
+1.90M
+98.13%
Jun 30, 2025
View more
Related ETFs
Updated: Tue, Dec 2
Updated: Tue, Dec 2
Name
Proportion
TCW Transform Systems ETF
6.65%
Gabelli Love Our Planet & People ETF
5.64%
Invesco S&P SmallCap Information Technology ETF
3.27%
Alpha Architect U.S. Quantitative Momentum ETF
1.78%
State Street SPDR S&P Kensho Future Security ETF
1.44%
Invesco S&P SmallCap 600 Pure Growth ETF
1.36%
Range Nuclear Renaissance Index ETF
1.26%
State Street SPDR S&P 600 Small Cap Growth ETF
0.99%
Vanguard S&P Small-Cap 600 Growth Index Fund
0.93%
iShares S&P Small-Cap 600 Growth ETF
0.91%
View more
TCW Transform Systems ETF
Proportion6.65%
Gabelli Love Our Planet & People ETF
Proportion5.64%
Invesco S&P SmallCap Information Technology ETF
Proportion3.27%
Alpha Architect U.S. Quantitative Momentum ETF
Proportion1.78%
State Street SPDR S&P Kensho Future Security ETF
Proportion1.44%
Invesco S&P SmallCap 600 Pure Growth ETF
Proportion1.36%
Range Nuclear Renaissance Index ETF
Proportion1.26%
State Street SPDR S&P 600 Small Cap Growth ETF
Proportion0.99%
Vanguard S&P Small-Cap 600 Growth Index Fund
Proportion0.93%
iShares S&P Small-Cap 600 Growth ETF
Proportion0.91%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of Mirion Technologies Inc?
The top five shareholders of Mirion Technologies Inc are:
BlackRock Institutional Trust Company, N.A. holds 14.04M shares, accounting for 5.75% of the total shares.
The Vanguard Group, Inc. holds 23.72M shares, accounting for 9.71% of the total shares.
T. Rowe Price Investment Management, Inc. holds 20.96M shares, accounting for 8.58% of the total shares.
State Street Investment Management (US) holds 5.09M shares, accounting for 2.09% of the total shares.
Omega Advisors, Inc. holds 7.13M shares, accounting for 2.92% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 14.04M shares, accounting for 5.75% of the total shares.
The Vanguard Group, Inc. holds 23.72M shares, accounting for 9.71% of the total shares.
T. Rowe Price Investment Management, Inc. holds 20.96M shares, accounting for 8.58% of the total shares.
State Street Investment Management (US) holds 5.09M shares, accounting for 2.09% of the total shares.
Omega Advisors, Inc. holds 7.13M shares, accounting for 2.92% of the total shares.
What are the top three shareholder types of Mirion Technologies Inc?
The top three shareholder types of Mirion Technologies Inc are:
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
T. Rowe Price Investment Management, Inc.
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
T. Rowe Price Investment Management, Inc.
How many institutions hold shares of Mirion Technologies Inc (MIR)?
As of 2025Q3, 568 institutions hold shares of Mirion Technologies Inc, with a combined market value of approximately 218.98M, accounting for 88.36% of the total shares. Compared to 2025Q2, institutional shareholding has increased by -0.40%.
What is the biggest source of revenue for Mirion Technologies Inc?
In FY2025Q2, the Nuclear business generated the highest revenue for Mirion Technologies Inc, amounting to 82.10M and accounting for 36.83% of total revenue.
